IBDEI1CY ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22633,1,3,0)
 ;;=3^Anemia,Aplastic,Drug-Induced
 ;;^UTILITY(U,$J,358.3,22633,1,4,0)
 ;;=4^D61.1
 ;;^UTILITY(U,$J,358.3,22633,2)
 ;;=^5002336
 ;;^UTILITY(U,$J,358.3,22634,0)
 ;;=D61.2^^104^1054^6
 ;;^UTILITY(U,$J,358.3,22634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22634,1,3,0)
 ;;=3^Anemia,Aplastic d/t External Agents
 ;;^UTILITY(U,$J,358.3,22634,1,4,0)
 ;;=4^D61.2
 ;;^UTILITY(U,$J,358.3,22634,2)
 ;;=^5002337
 ;;^UTILITY(U,$J,358.3,22635,0)
 ;;=D61.89^^104^1054^9
 ;;^UTILITY(U,$J,358.3,22635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22635,1,3,0)
 ;;=3^Anemia,Aplastic/Bone Marrow Failure Syndromes
 ;;^UTILITY(U,$J,358.3,22635,1,4,0)
 ;;=4^D61.89
 ;;^UTILITY(U,$J,358.3,22635,2)
 ;;=^5002341
 ;;^UTILITY(U,$J,358.3,22636,0)
 ;;=D61.9^^104^1054^8
 ;;^UTILITY(U,$J,358.3,22636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22636,1,3,0)
 ;;=3^Anemia,Aplastic,Unspec
 ;;^UTILITY(U,$J,358.3,22636,1,4,0)
 ;;=4^D61.9
 ;;^UTILITY(U,$J,358.3,22636,2)
 ;;=^5002342
 ;;^UTILITY(U,$J,358.3,22637,0)
 ;;=D59.0^^104^1054^10
 ;;^UTILITY(U,$J,358.3,22637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22637,1,3,0)
 ;;=3^Anemia,Drug-Induced Autoimmune Hemolytic
 ;;^UTILITY(U,$J,358.3,22637,1,4,0)
 ;;=4^D59.0
 ;;^UTILITY(U,$J,358.3,22637,2)
 ;;=^5002323
 ;;^UTILITY(U,$J,358.3,22638,0)
 ;;=D62.^^104^1054^20
 ;;^UTILITY(U,$J,358.3,22638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22638,1,3,0)
 ;;=3^Anemia,Posthemorrhagic,Acute
 ;;^UTILITY(U,$J,358.3,22638,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,22638,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,22639,0)
 ;;=D64.81^^104^1054^1
 ;;^UTILITY(U,$J,358.3,22639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22639,1,3,0)
 ;;=3^Anemia d/t Antineoplastic Chemotherapy
 ;;^UTILITY(U,$J,358.3,22639,1,4,0)
 ;;=4^D64.81
 ;;^UTILITY(U,$J,358.3,22639,2)
 ;;=^5002349
 ;;^UTILITY(U,$J,358.3,22640,0)
 ;;=D63.1^^104^1054^4
 ;;^UTILITY(U,$J,358.3,22640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22640,1,3,0)
 ;;=3^Anemia in Chr Kidney Disease
 ;;^UTILITY(U,$J,358.3,22640,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,22640,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,22641,0)
 ;;=D63.0^^104^1054^5
 ;;^UTILITY(U,$J,358.3,22641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22641,1,3,0)
 ;;=3^Anemia in Neoplastic Disease
 ;;^UTILITY(U,$J,358.3,22641,1,4,0)
 ;;=4^D63.0
 ;;^UTILITY(U,$J,358.3,22641,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,22642,0)
 ;;=D63.8^^104^1054^3
 ;;^UTILITY(U,$J,358.3,22642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22642,1,3,0)
 ;;=3^Anemia in Chr Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,22642,1,4,0)
 ;;=4^D63.8
 ;;^UTILITY(U,$J,358.3,22642,2)
 ;;=^5002343
 ;;^UTILITY(U,$J,358.3,22643,0)
 ;;=D51.8^^104^1054^27
 ;;^UTILITY(U,$J,358.3,22643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22643,1,3,0)
 ;;=3^Anemia,Vitamin B12 Deficiency
 ;;^UTILITY(U,$J,358.3,22643,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,22643,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,22644,0)
 ;;=D51.1^^104^1054^2
 ;;^UTILITY(U,$J,358.3,22644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22644,1,3,0)
 ;;=3^Anemia d/t Selective Vit B12 Malabsorption w/ Proteinuria
 ;;^UTILITY(U,$J,358.3,22644,1,4,0)
 ;;=4^D51.1
 ;;^UTILITY(U,$J,358.3,22644,2)
 ;;=^5002285
 ;;^UTILITY(U,$J,358.3,22645,0)
 ;;=D53.9^^104^1054^19
 ;;^UTILITY(U,$J,358.3,22645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22645,1,3,0)
 ;;=3^Anemia,Nutritional,Unspec
 ;;^UTILITY(U,$J,358.3,22645,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,22645,2)
 ;;=^5002298
 ;;^UTILITY(U,$J,358.3,22646,0)
 ;;=D52.9^^104^1054^13
 ;;^UTILITY(U,$J,358.3,22646,1,0)
 ;;=^358.31IA^4^2
